UMOD | Uromodulin | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
TMEM174 | Transmembrane protein 174 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
KNG1 | Kininogen 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
AFM | Afamin | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
NPHS2 | Nephrosis 2, idiopathic, steroid-resistant (podocin) | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Group enriched |
MIOX | Myo-inositol oxygenase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
ALDH8A1 | Aldehyde dehydrogenase 8 family, member A1 | Predicted intracellular proteins
| | | | | Group enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC36A2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
POU3F3 | POU class 3 homeobox 3 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
FTCD | Formimidoyltransferase cyclodeaminase | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM52B | Transmembrane protein 52B | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FXYD4 | FXYD domain containing ion transport regulator 4 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
UPB1 | Ureidopropionase, beta | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CALB1 | Calbindin 1, 28kDa | Predicted intracellular proteins
| | | | | Tissue enriched |
TREH | Trehalase (brush-border membrane glycoprotein) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
DMGDH | Dimethylglycine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
SLC5A12 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 | Predicted membrane proteins Transporters
| | | | | Group enriched |
APOM | Apolipoprotein M | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | Predicted intracellular proteins
| | | | | Tissue enriched |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |